Search research articles
Contact Us
Filters
Showing results (21-30 of 70) with videos related to
Page
of 7
Sort By:
Diabetes Technology & Therapeutics
|
May 1, 2004
Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system
Bruce Bode, Kenneth Gross, Nancy Rikalo, et al.
Diabetes Technology & Therapeutics
|
May 27, 2020
Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy
Maciej T Malecki, Dachuang Cao, Rong Liu, et al.
Diabetes Care
|
January 29, 2005
Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs
Philip Raskin, Elsie Allen, Priscilla Hollander, et al.
Diabetes Care
|
August 11, 2016
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 18, 2010
A valuation of infusion therapy to preserve islet function in type 1 diabetes
Andrew Lloyd, Paul Swinburn, Kristina S Boye, et al.
Diabetes, Obesity & Metabolism
|
April 18, 2019
Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring
Jeremy Pettus, Jasvinder Gill, Sachin Paranjape, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials
Bernard Zinman, J Hans DeVries, Bruce Bode, et al.
Journal of Medical Economics
|
June 14, 2016
Economic impact of hypoglycemia among insulin-treated patients with diabetes
Matthew Sussman, Joseph A Sierra, Satish Garg, et al.
Mayo Clinic Proceedings
|
December 15, 2004
Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial
Robert Tanenberg, Bruce Bode, Wendy Lane, et al.
BMC Endocrine Disorders
|
April 19, 2014
Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies
Alan Sinclair, Bruce Bode, Stewart Harris, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 70) with videos related to
Sort By:
Page
of 7
Diabetes Technology & Therapeutics
|
May 1, 2004
Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system
Bruce Bode, Kenneth Gross, Nancy Rikalo, et al.
Diabetes Technology & Therapeutics
|
May 27, 2020
Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy
Maciej T Malecki, Dachuang Cao, Rong Liu, et al.
Diabetes Care
|
January 29, 2005
Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs
Philip Raskin, Elsie Allen, Priscilla Hollander, et al.
Diabetes Care
|
August 11, 2016
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 18, 2010
A valuation of infusion therapy to preserve islet function in type 1 diabetes
Andrew Lloyd, Paul Swinburn, Kristina S Boye, et al.
Diabetes, Obesity & Metabolism
|
April 18, 2019
Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring
Jeremy Pettus, Jasvinder Gill, Sachin Paranjape, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials
Bernard Zinman, J Hans DeVries, Bruce Bode, et al.
Journal of Medical Economics
|
June 14, 2016
Economic impact of hypoglycemia among insulin-treated patients with diabetes
Matthew Sussman, Joseph A Sierra, Satish Garg, et al.
Mayo Clinic Proceedings
|
December 15, 2004
Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial
Robert Tanenberg, Bruce Bode, Wendy Lane, et al.
BMC Endocrine Disorders
|
April 19, 2014
Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies
Alan Sinclair, Bruce Bode, Stewart Harris, et al.
Page
of 7